Contrast mammography for women with dense breasts and prior breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether contrast-enhanced mammography (a special mammogram with a dye injection) can help find breast cancers in women who have had breast cancer before and have dense breasts. You would get this test in addition to your normal screening, and it may offer better detection than ultrasound alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 50 and 69.
- You have had breast cancer in the past and currently have dense breast tissue (category C or D).
- Your most recent mammogram was normal (no signs of cancer).
- You are already scheduled for a supplemental ultrasound at the study center.
- You are willing to receive an IV contrast injection (a dye that helps highlight areas in the breast).
- You have no kidney problems, no thyroid disease, and no history of allergic reactions to iodine-based contrast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
This trial compares two imaging tests—CESM (a contrast-enhanced mammogram) and DBT (3D mammography)—to see which works best for women with dense breast tissue. It may help improve how early breast changes are found in dense breasts.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This trial offers extra screening (MRI or contrast-enhanced mammogram) for women with extremely dense breast tissue who have had a normal mammogram. The goal is to see if these extra tests can find cancers that might be missed by standard mammography.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.